218 related articles for article (PubMed ID: 8541390)
21. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.
Mazhar D; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2006 Mar; 6(3):335-41. PubMed ID: 16503851
[TBL] [Abstract][Full Text] [Related]
22. Primary central nervous system lymphoma.
Stern JI; Raizer JJ
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
[TBL] [Abstract][Full Text] [Related]
23. [Nervous system lymphoma in HIV infection].
Mikol J; Polivka M; Gyuris A; Minarovits J; Morinet F
Arch Anat Cytol Pathol; 1997; 45(2-3):164-73. PubMed ID: 9382609
[TBL] [Abstract][Full Text] [Related]
24. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology, clinical characteristics, and management of AIDS-related lymphoma.
Levine AM
Hematol Oncol Clin North Am; 1991 Apr; 5(2):331-42. PubMed ID: 2022597
[TBL] [Abstract][Full Text] [Related]
26. [Primary non-Hodgkin's malignant lymphoma of the central nervous system].
Monjour A; Poisson M; Kujas M; Delattre JY
Rev Neurol (Paris); 1992; 148(10):589-600. PubMed ID: 1295053
[TBL] [Abstract][Full Text] [Related]
27. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
28. AIDS-related primary central nervous system lymphoma.
Kasamon YL; Ambinder RF
Hematol Oncol Clin North Am; 2005 Aug; 19(4):665-87, vi-vii. PubMed ID: 16083829
[TBL] [Abstract][Full Text] [Related]
29. Acquired immunodeficiency syndrome-associated lymphomas.
Freter CE
J Natl Cancer Inst Monogr; 1990; (10):45-54. PubMed ID: 2189476
[TBL] [Abstract][Full Text] [Related]
30. Current management of primary central nervous system lymphoma.
Deangelis LM
Oncology (Williston Park); 1995 Jan; 9(1):63-71; discussion 71, 75-6, 78. PubMed ID: 7718442
[TBL] [Abstract][Full Text] [Related]
31. [Secondary non-Hodgkin's lymphomas].
Cappelaere P
Bull Cancer; 1998 Mar; 85(3):217-31. PubMed ID: 9752310
[TBL] [Abstract][Full Text] [Related]
32. [Initial clinicopathological manifestations of malignant lymphoproliferative processes in patients with human immunodeficiency virus seropositivity. Study of 40 cases].
Bellmunt J; Ribas A; Ocaña I; Capdevila JA; Ruiz-Marcellan MC; Giralt J; Sole LA
An Med Interna; 1994 May; 11(5):217-23. PubMed ID: 8061135
[TBL] [Abstract][Full Text] [Related]
33. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
[TBL] [Abstract][Full Text] [Related]
34. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects.
Levine AM
Semin Oncol; 2000 Aug; 27(4):442-53. PubMed ID: 10950371
[TBL] [Abstract][Full Text] [Related]
35. [AIDS-related non-Hodgkin lymphomas. Clinical picture and prognosis].
Penkowa M; Hansen PB
Ugeskr Laeger; 1998 Apr; 160(18):2685-8. PubMed ID: 9599550
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
[TBL] [Abstract][Full Text] [Related]
37. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival of patients with HIV-related systemic non-Hodgkin's lymphomas.
Tirelli U; Errante D; Spina M; Vaccher E; Serraino D; Boiocchi M; Gloghini A; Carbone A
Hematol Oncol; 1996 Mar; 14(1):7-15. PubMed ID: 8613137
[TBL] [Abstract][Full Text] [Related]
39. International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients.
Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Gómez J; Millá F; Feliu E
Haematologica; 1998 Jun; 83(6):508-13. PubMed ID: 9676023
[TBL] [Abstract][Full Text] [Related]
40. Biology of disease and clinical aspects of AIDS-associated lymphoma: a review.
Stein ME; Spencer D; Dansey R; Bezwoda WR
East Afr Med J; 1994 Apr; 71(4):219-22. PubMed ID: 8062766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
